Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for ISONIAZID; RIFAMPIN
- Short-course Regimens for the Treatment of Pulmonary Tuberculosis
- Sitafloxacin-containing Regimens for Shortening Tuberculosis Treatment
- Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB
- Short-course Rifamycin-based Regimens for Latent Tuberculosis in Patients With End-stage Kidney Disease
- Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)
- A New Treatment for Primary Smear-positive Pulmonary Tuberculosis With Interleukin-2
- Efficacy and Safety of Isoniazid, Rifampicin and Moxifloxacin for the Intensive Phase of Initial Therapy of PTB
- Risk of SDRs Under 3HP and 1HP Regimen for LTBI
- Azacytidine During Anti-tuberculosis Therapy
- Optimizing Antituberculosis Therapy in Adults With Tuberculous Meningitis
- Pilot Clinical Trial of PRS TB Regimen I - Phase II
- Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI
- Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and Levofloxacin
- Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis
- A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of Tuberculosis
- Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis
- TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens
- NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis
- Assessing PA-824 for Tuberculosis (the APT Trial)
- Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study)
- A Study to Evaluate the Efficacy and Safety of TMC207 in Patients With Pulmonary Infection With Multi-drug Resistant Mycobacterium Tuberculosis
- Early Access of TMC207 in Patients With Extensively Drug Resistant or Pre-XDR Pulmonary Tuberculosis
- Trial of High-Dose Rifampin in Patients With TB
- Comparing Two Preventive Regimens for Latent Tuberculosis Infection (LTBI)
- Reintroduction Regimens After Hepatitis During Anti-tuberculosis Treatment
- Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness
- Study of Daily Rifapentine for Pulmonary Tuberculosis
- Active Screening of Latent TB Infection, Treatment and Long Term Follow-up in Prison
- Rifapentine Plus Moxifloxacin for Treatment of Pulmonary Tuberculosis
- Efficacy of Thrice Weekly Directly Observed Treatment, Short-course (DOTS) in HIV-associated Tuberculosis
- TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment
- Investigation of the Effect of N Acetylcysteine Against Anti-Tuberculosis Drugs Induced Liver Toxicity
- TMC207-C202: Study to Evaluate Bactericidal Activity of Multiple Oral Doses of TMC207 in Subjects With Sputum-Smear Positive Tuberculosis
- A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy
- Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis
- Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis Infection
- A Randomized Trial of DOTS Versus Enhanced DOTS for Community Control of Tuberculosis
- Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9)
- TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB Treatment
- TBTC Study 28: Moxifloxacin Versus Isoniazid for TB Treatment
- TBTC Study 27: Moxifloxacin vs Ethambutol for TB Treatment
- Treatment of Latent TB Infection for Jailed Persons
- Moxifloxacin As Part of a Multi-Drug Regimen For Tuberculosis
- TBTC Study 24: Intermittent Treatment of TB With Isoniazid Resistance or Intolerance
- TBTC Study 22: Efficacy of Once-Weekly Rifapentine and Isoniazid in Treatment of Tuberculosis
- The Treatment of Tuberculosis in HIV-Infected Patients
- Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis
- A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDR
- Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
- Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
Clinical trials list
click for details